Immune Persistence, Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered as a Booster Dose in Adolescents and Adults Vaccinated Against Meningococcal Disease 3-6 Years Earlier

被引：0
|
作者：
Dhingra, Mandeep Singh S.
Peterson, James
Deseda, Carmen
Julien, Katie
Zambrano, Betzana
Anez, German
Shi, Jiayuan
Pan, Judy
Arroum, Habiba
Varghese, Kucku
Jordanov, Emilia
机构：
来源：
PEDIATRICS | 2022年 / 149卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
260
引用
收藏
页数：2
相关论文
共 31 条
  • [1] Five-Year Immune Persistence of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) and Immunogenicity and Safety of a Booster Dose in Children
    Martinon-Torres, Federico
    Simko, Robert
    Ebert, Rolf
    Ramet, Mika
    Zocchetti, Celine
    Syrkina, Olga
    Bchir, Siham
    Bertrand-Gerentes, Isabelle
    INFECTIOUS DISEASES AND THERAPY, 2025,
  • [2] Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study
    Robertson, Corwin A.
    Jacqmein, Jeffry
    Selmani, Alexandre
    Galarza, Katherine
    Oster, Philipp
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [3] Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study
    Anez, German
    Hedrick, James
    Simon, Michael W.
    Christensen, Shane
    Jeanfreaue, Robert
    Yau, Eddy
    Pan, Judy
    Jordanov, Emilia
    Dhingra, Mandeep S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (06) : 1292 - 1298
  • [4] Safety and Immunogenicity Of A Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered In Healthy Meningococcal Vaccine-Naive Children (2-9 Years)
    Simon, Michael
    Zomcik, Anne
    Brandon, Donald
    Christensen, Shane
    Baccarini, Carmen
    Jordanov, Emilia
    Dhingra, Mandeep S.
    PEDIATRICS, 2021, 147 (03)
  • [5] Immune persistence and booster response of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) 5 years after primary vaccination of adults at ≥56 years of age
    Robertson, Corwin A.
    Jacqmein, Jeffry
    Selmani, Alexandre
    Galarza, Katherine
    Oster, Philipp
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [6] A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States
    Chang, Lee-Jah
    Hedrick, James
    Christensen, Shane
    Pan, Judy
    Jordanov, Emilia
    Dhingra, Mandeep S.
    VACCINE, 2020, 38 (19) : 3560 - 3569
  • [7] Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT): A review of the evidence and expert opinion
    Ricci, Silvia
    Azzari, Chiara
    Amodio, Emanuele
    Castiglia, Paolo
    EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 447 - 456
  • [8] Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study
    Piazza, Franco M.
    Virta, Miia
    Paassilta, Marita
    Ukkonen, Benita
    Ahonen, Anitta
    Esteves-Jaramillo, Alejandra
    Forsten, Aino
    Seppa, Ilkka
    Ding, Jian
    Neveu, David
    Jordanov, Emilia
    Dhingra, Mandeep S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01) : 1 - 10
  • [9] Immunogenicity, safety and inter-lot consistency of a meningococcal conjugate vaccine (MenACYW-TT) in adolescents and adults: A Phase III randomized study
    Dhingra, Mandeep S.
    Peterson, James
    Hedrick, James
    Pan, Judy
    Neveu, David
    Jordanov, Emilia
    VACCINE, 2020, 38 (33) : 5194 - 5201
  • [10] Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study
    Kirstein, Judith
    Pina, Miriam
    Pan, Judy
    Jordanov, Emilia
    Dhingra, Mandeep S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (06) : 1299 - 1305
1234